A Phase I Dose Escalation Trial Of Mage-A3 And Hpv-16 Specific Peptide Inurnanotandulatory Vaccines In Patients With Recurrent/Inetastatic (Rm) Squamous Cell Carcinoma Of The Head And Neck (Scchn).
JOURNAL OF CLINICAL ONCOLOGY（2014）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要